Theranostics of Primary Prostate Cancer: Beyond PSMA and GRP-R.

Schollhammer, Romain; Quintyn Ranty, Marie-Laure; de Clermont Gallerande, Henri; Cavelier, Florine; Valverde, Ibai E; Vimont, Delphine; Hindié, Elif; Morgat, Clément

Schollhammer, Romain; Quintyn Ranty, Marie-Laure; de Clermont Gallerande, Henri; Cavelier, Florine; Valverde, Ibai E; Vimont, Delphine; Hindié, Elif; Morgat, Clément.

Afiliação

Schollhammer R; Nuclear Medicine Department, Bordeaux University Hospital, 33000 Bordeaux, France.
Quintyn Ranty ML; INCIA, University of Bordeaux, CNRS, EPHE, UMR 5287, 33000 Bordeaux, France.
de Clermont Gallerande H; Department of Pathology, University Hospital of Toulouse, 31000 Toulouse, France.
Cavelier F; Nuclear Medicine Department, Bordeaux University Hospital, 33000 Bordeaux, France.
Valverde IE; INCIA, University of Bordeaux, CNRS, EPHE, UMR 5287, 33000 Bordeaux, France.
Vimont D; Institut des Biomolécules Max Mousseron IBMM, UMR 5247, CNRS, Université Montpellier, ENSCM, Pôle Chimie Balard, 1919 Route de Mende, Cedex 5, 34293 Montpellier, France.
Hindié E; Institut de Chimie Moléculaire de l'Université de Bourgogne, UMR 6302, CNRS, Université Bourgogne Franche-Comté, 9 Avenue Alain Savary, 21000 Dijon, France.
Morgat C; INCIA, University of Bordeaux, CNRS, EPHE, UMR 5287, 33000 Bordeaux, France.

Cancers (Basel) ; 15(8)2023 Apr 18.

Article em En | MEDLINE | ID: mdl-37190273

Palavras-chave

GRP-R; NTS1; NTS2; PSMA; neuropeptide; neurotensin; prostate cancer

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Cancers (Basel) Ano de publicação: 2023 Tipo de documento: Article País de afiliação: França

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google